Dose intense chemotherapy in the management of poor prognosis and relapsed testicular cancer: experiences and controversies
dc.contributor.author | Ng, K | en_US |
dc.contributor.author | Duncan, S | en_US |
dc.contributor.author | Shamash, J | en_US |
dc.contributor.author | Alifrangis, C | en_US |
dc.date.accessioned | 2020-10-21T15:04:57Z | |
dc.date.issued | 2018 | en_US |
dc.identifier.issn | 1473-7140 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67678 | |
dc.format.extent | 431 - 436 | en_US |
dc.relation.ispartof | EXPERT REVIEW OF ANTICANCER THERAPY | en_US |
dc.subject | Testicular cancer | en_US |
dc.subject | metastatic disease | en_US |
dc.subject | poor risk | en_US |
dc.subject | relapse | en_US |
dc.subject | chemotherapy | en_US |
dc.subject | salvage | en_US |
dc.title | Dose intense chemotherapy in the management of poor prognosis and relapsed testicular cancer: experiences and controversies | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1080/14737140.2018.1454313 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429352500003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 18 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |